BTX-A51

· Edgewood Oncology Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BTX-A51, covering 2025-01-30 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma [Phase 1]